These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bortezomib for acute humoral rejection in two repeat transplant recipients. Hardinger KL; Alford K; Murillo D Clin Transpl; 2009; ():479-83. PubMed ID: 20524319 [TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibition for antibody-mediated rejection. Everly JJ; Walsh RC; Alloway RR; Woodle ES Curr Opin Organ Transplant; 2009 Dec; 14(6):662-6. PubMed ID: 19667989 [TBL] [Abstract][Full Text] [Related]
5. Case presentations on two patients who received bortezomib for antibody mediated rejection at BIDMC. Pavlakis M Clin Transpl; 2009; ():343-5. PubMed ID: 20524296 [TBL] [Abstract][Full Text] [Related]
6. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection. Hardinger KL; Murillo D Clin Transpl; 2011; ():401-8. PubMed ID: 22755438 [TBL] [Abstract][Full Text] [Related]
8. High immunologic risk living donor kidney transplant using bortezomib in a novel induction regimen without acute antibody mediated rejection. Dunn TB; Borja-Cacho D; Chinnakotla S; Finger E; Tamayo G; Verghese P; Kim Y; Manivel C; Kandaswamy R; Matas A; Pruett T; Noreen H; Krefting P; Maurer D Clin Transpl; 2011; ():381-7. PubMed ID: 22755435 [TBL] [Abstract][Full Text] [Related]
9. The use of bortezomib as a rescue treatment for acute antibody-mediated rejection: report of three cases and review of literature. Tzvetanov I; Spaggiari M; Joseph J; Jeon H; Thielke J; Oberholzer J; Benedetti E Transplant Proc; 2012 Dec; 44(10):2971-5. PubMed ID: 23195008 [TBL] [Abstract][Full Text] [Related]
13. Bortezomib in the treatment of antibody-mediated rejection--a report of 3 cases. Mai HL; Cesbron A; Brouard S; Blanchol G; Cantarovich D; Dantal J; Hourmant M; Lino M; Meurette A; Gosselin M; Abbadie O; Soulillou JP; Giral M Clin Transpl; 2009; ():361-8. PubMed ID: 20524299 [No Abstract] [Full Text] [Related]
14. Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report. Schwaiger E; Regele H; Wahrmann M; Werzowa J; Haidbauer B; Schmidt A; Böhmig GA Clin Transpl; 2010; ():391-6. PubMed ID: 21696056 [TBL] [Abstract][Full Text] [Related]
15. Bortezomib is effective to treat acute humoral rejection after liver transplantation. Lee CF; Eldeen FZ; Chan KM; Wu TH; Soong RS; Wu TJ; Chou HS; Lee WC Transplant Proc; 2012 Mar; 44(2):529-31. PubMed ID: 22410063 [TBL] [Abstract][Full Text] [Related]
16. Treatment of acute antibody-mediated rejection using bortezomib: a case report. Sin YH; Kim YJ; Oh JS; Lee JH; Kim SM; Kim JK Nephrology (Carlton); 2015 Jul; 20 Suppl 2():86-9. PubMed ID: 26031595 [TBL] [Abstract][Full Text] [Related]
17. Antihumoral rejection therapy by proteasome inhibitor bortezomib: a case series. Lachmann N; Schütz M; Budde K; Schönemann C; Waiser J Clin Transpl; 2009; ():351-8. PubMed ID: 20527073 [TBL] [Abstract][Full Text] [Related]
18. Use of bortezomib for treatment of antibody medicated rejection in kidney transplant recipients--case report. Hamawi K; Heilman RL; Mazur MJ; Chakkera HA; Mulligan DC; Moss AA; Mekeel KL; Reddy KS Clin Transpl; 2009; ():407-14. PubMed ID: 20524306 [No Abstract] [Full Text] [Related]
19. Bortezomib as rescue therapy for antibody mediated rejection: a single-center experience. Hardinger KL; Alford K; Murillo D Clin Transpl; 2010; ():429-36. PubMed ID: 21696060 [TBL] [Abstract][Full Text] [Related]